Markets Weekahead
Too good to last much longer
The markets have run up too fast too soon to sustain without a healthy correction. In the near term, global markets cues, FII activities and rupee movement remain the key, writes Ambareesh Baliga. Full Article
Reuters Showcase
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
Dishman close to deal with AstraZeneca, Merck-source
MUMBAI |
MUMBAI (Reuters) - Dishman Pharmaceuticals & Chemicals Ltd is close to signing contracts with U.S. Merck & Co Inc and AstraZeneca for supplying bulk drugs, a source close to the deal said on Tuesday.
"The contracts are expected to be signed in a month's time," the source, who declined to be named told Reuters.
Dishman already has a long-term contract manufacturing deal with Dutch Solvay for supplying bulk drugs and intermediates.
Global pharmaceutical giants are increasingly outsourcing drug manufacturing to companies in India as they seek to benefit from lower manufacturing costs here.
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters